American cancer patients have collectively gained up to 14 million years of life since 1980 as a result of NCI-funded cancer trials conducted by the National Clinical Trials Network, a study led by SWOG Cancer Research Network found.
NCI has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation.
On Aug. 5, two months into her job as CEO of the American Cancer Society, Karen Knudsen was in Burlington, VT, checking out the Hope Lodge—the third one she visited since taking the job.
Incredible advances in cancer care are of no benefit to cancer patients if they can’t access them. Sadly, for too many cancer patients, our current system places barriers in their path to accessing the optimal clinical care for their diagnosis.
Directors of the first three NCI-designated Comprehensive Cancer Centers are learning from the past, starting with the National Cancer Act, and mapping an equitable future for oncology.
The vast majority of hospitals in the United States—up to 80%—treat patient populations that are disproportionately white, U.S. News & World Report said, unveiling a new suite of health equity measures earlier this week.
When Ben Harder and his team of health analysts at U.S. News & World Report developed a suite of health equity measures for America’s hospitals, they expected to find some level of disparity, but nothing prepared them for the shocking magnitude of inequity they uncovered.
To comprehend the significance of disparities articulated in the U.S. News study and define the scorecards’ impact on bragging rights at cancer centers, The Cancer Letter asked four leaders in oncology to evaluate the health equity measures.
As a comprehensive cancer center in Los Angeles, City of Hope serves one of the most diverse—and vulnerable—patient populations in the U.S.
Two academic health systems in Cleveland are creating programs and faculty positions to direct institutional initiatives on health equity—at the executive level.
